Riccardo Centurioni

1.5k total citations
40 papers, 685 citations indexed

About

Riccardo Centurioni is a scholar working on Hematology, Oncology and Molecular Biology. According to data from OpenAlex, Riccardo Centurioni has authored 40 papers receiving a total of 685 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Hematology, 17 papers in Oncology and 13 papers in Molecular Biology. Recurrent topics in Riccardo Centurioni's work include Multiple Myeloma Research and Treatments (12 papers), Complement system in diseases (11 papers) and Protein Degradation and Inhibitors (6 papers). Riccardo Centurioni is often cited by papers focused on Multiple Myeloma Research and Treatments (12 papers), Complement system in diseases (11 papers) and Protein Degradation and Inhibitors (6 papers). Riccardo Centurioni collaborates with scholars based in Italy, United States and Canada. Riccardo Centurioni's co-authors include Pietro Leoni, Camillo Porta, E Bobbio-Pallavicini, F Tacconi, Massimo Offidani, Atto Billio, L Gugliotta, Attilio Olivieri, E Ascari and Marino Brunori and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and British Journal of Haematology.

In The Last Decade

Riccardo Centurioni

38 papers receiving 664 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Riccardo Centurioni Italy 15 457 236 213 156 101 40 685
Radovan Sašo United Kingdom 22 846 1.9× 384 1.6× 311 1.5× 278 1.8× 86 0.9× 50 1.2k
Seung‐Ah Yahng South Korea 18 752 1.6× 193 0.8× 280 1.3× 160 1.0× 72 0.7× 88 1.0k
Gabrielle Meyers United States 15 334 0.7× 124 0.5× 174 0.8× 85 0.5× 58 0.6× 43 602
Kenneth Douglas United Kingdom 12 423 0.9× 132 0.6× 462 2.2× 59 0.4× 235 2.3× 23 886
Sabina Kersting Netherlands 11 269 0.6× 132 0.6× 231 1.1× 33 0.2× 68 0.7× 20 545
B Dey United States 12 417 0.9× 170 0.7× 426 2.0× 60 0.4× 27 0.3× 22 845
Prentice Hg United Kingdom 14 354 0.8× 177 0.8× 145 0.7× 87 0.6× 22 0.2× 20 622
Razvan Diaconescu United States 12 854 1.9× 278 1.2× 298 1.4× 57 0.4× 29 0.3× 18 1.1k
Sam Penza United States 17 467 1.0× 321 1.4× 188 0.9× 103 0.7× 14 0.1× 63 806
Simona Pagliuca France 14 314 0.7× 104 0.4× 176 0.8× 125 0.8× 28 0.3× 69 594

Countries citing papers authored by Riccardo Centurioni

Since Specialization
Citations

This map shows the geographic impact of Riccardo Centurioni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Riccardo Centurioni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Riccardo Centurioni more than expected).

Fields of papers citing papers by Riccardo Centurioni

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Riccardo Centurioni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Riccardo Centurioni. The network helps show where Riccardo Centurioni may publish in the future.

Co-authorship network of co-authors of Riccardo Centurioni

This figure shows the co-authorship network connecting the top 25 collaborators of Riccardo Centurioni. A scholar is included among the top collaborators of Riccardo Centurioni based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Riccardo Centurioni. Riccardo Centurioni is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Offidani, Massimo, Laura Corvatta, Claudia Polloni, et al.. (2011). Infectious complications in patients with multiple myeloma treated with new drug combinations containing thalidomide. Leukemia & lymphoma. 52(5). 776–785. 17 indexed citations
2.
Rossi, Mônica Lanzoni, et al.. (2011). Autologus peripheral stem cell transplantation in a patient with diffuse systemic sclerosis: our experience. SHILAP Revista de lepidopterología. 56(1). 51–6. 3 indexed citations
3.
Offidani, Massimo, Claudia Polloni, Laura Corvatta, et al.. (2011). Assessment of Frailty Measures and Their Effect on Survival in a Population of Patients Registered At Marche Region Multiple Myeloma (MM) Registry. Blood. 118(21). 2873–2873. 1 indexed citations
4.
Offidani, Massimo, Pietro Leoni, Laura Corvatta, et al.. (2010). ThaDD plus high dose therapy and autologous stem cell transplantation does not appear superior to ThaDD plus maintenance in elderly patients with de novo multiple myeloma. European Journal Of Haematology. 84(6). 474–483. 12 indexed citations
5.
Offidani, Massimo, Laura Corvatta, Claudia Polloni, et al.. (2008). Thalidomide‐dexamethasone versus Interferon‐alpha‐dexamethasone as maintenance treatment after ThaDD induction for multiple myeloma: a prospective, multicentre, randomised study. British Journal of Haematology. 144(5). 653–659. 23 indexed citations
6.
Nardi, Roberto, Giovanni Scanelli, Marco Grandi, et al.. (2007). The assessment of complexity in internal medicine patients. The FADOI Medicomplex Study. European Journal of Internal Medicine. 18(4). 283–287. 32 indexed citations
7.
Offidani, Massimo, Laura Corvatta, Giuseppe Visani, et al.. (2006). Low-dose thalidomide with pegylated liposomal doxorubicin and high-dose dexamethasone for relapsed/refractory multiple myeloma: a prospective, multicenter, phase II study.. PubMed. 91(1). 133–6. 62 indexed citations
8.
Offidani, Massimo, Laura Corvatta, Giuseppe Visani, et al.. (2005). Thalidomide, Dexamethasone and Pegylated-Liposomal Doxorubicin (ThaDD) for Untreated Multiple Myeloma Patients Aged over 65 Years.. Blood. 106(11). 2558–2558. 1 indexed citations
9.
Santini, Gino, Cármino Antônio De Souza, Savina Aversa, et al.. (2004). A third generation regimen VACOP-B with or without adjuvant radiotherapy for aggressive localized non-Hodgkin's lymphoma: report from the Italian Non-Hodgkin's Lymphoma Co-operative Study Group. Brazilian Journal of Medical and Biological Research. 37(5). 719–728. 1 indexed citations
10.
Offidani, Massimo, Laura Corvatta, Lara Malerba, et al.. (2004). Comparison of Two Regimens for the Treatment of Elderly Patients with Acute Lymphoblastic Leukaemia (ALL).. Blood. 104(11). 4490–4490. 4 indexed citations
11.
Offidani, Massimo, Laura Corvatta, Lara Malerba, et al.. (2004). Comparison of two regimens for the treatment of elderly patients with acute lymphoblastic leukaemia (ALL). Leukemia & lymphoma. 46(2). 233–238. 13 indexed citations
12.
Offidani, Massimo, Laura Corvatta, Riccardo Centurioni, et al.. (2003). High-dose daunorubicin as liposomal compound (Daunoxome®) in elderly patients with acute lymphoblastic leukemia1. The Hematology Journal. 4(1). 47–53. 18 indexed citations
13.
Olivieri, Attilio, Debora Capelli, Mauro Montanari, et al.. (2001). Very low toxicity and good quality of life in 48 elderly patients autotransplanted for hematological malignancies: a single center experience. Bone Marrow Transplantation. 27(11). 1189–1195. 32 indexed citations
14.
Offidani, Massimo, Laura Corvatta, Attilio Olivieri, et al.. (1999). Infectious complications after autologous peripheral blood progenitor cell transplantation followed by G-CSF. Bone Marrow Transplantation. 24(10). 1079–1087. 53 indexed citations
15.
Olivieri, Attilio, Massimo Offidani, Mauro Montanari, et al.. (1998). Factors affecting hemopoietic recovery after high-dose therapy and autologous peripheral blood progenitor cell transplantation: a single center experience.. PubMed. 83(4). 329–37. 45 indexed citations
16.
Montillo, Marco, Alessandra Tedeschi, Riccardo Centurioni, & Pietro Leoni. (1997). Treatment of Relapsed Adult Acute Lymphoblastic Leukemia with Fludarabine and Cytosine Arabinoside Followed by Granulocyte Colony-Stimulating Factor (FLAG-GCSF). Leukemia & lymphoma. 25(5-6). 579–583. 34 indexed citations
17.
Porta, Camillo, et al.. (1996). Thrombotic Thrombocytopenic Purpura and Relapes: Why do case series differ?. American Journal of Hematology. 52(3). 215–216. 1 indexed citations
18.
Bobbio-Pallavicini, E, Camillo Porta, Riccardo Centurioni, et al.. (1994). Vincristine sulfate for the treatment of thrombotic thrombocytopenic purpura refractory to plasma‐exchange. European Journal Of Haematology. 52(4). 222–226. 51 indexed citations
19.
Centurioni, Riccardo, Pietro Leoni, Serena Rupoli, et al.. (1992). Antiplatelet agents for the treatment of thrombotic thrombocytopenic purpura. Transfusion Science. 13(1). 77–87. 4 indexed citations
20.
Leoni, Pietro, Attilio Olivieri, Riccardo Centurioni, & Marco Montillo. (1983). Bone marrow cryopreservation: biological aspects.. PubMed. 59(8). 1089–95. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026